A prospective and cohort study involving 3879 patients with a mean eGFR of 42.8 mL/min showed that an increased FGF23 level predicted the prognosis of CKD, specifically, a significantly high mortality and disease progression to end-stage kidney disease [41]. This evidence concerns the gene FGF23 and chronic kidney disease.